{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:54:21Z","timestamp":1793364861840,"version":"4.5.0"},"reference-count":22,"publisher":"Society of Nuclear Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.2967\/jnumed.121.262782","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T16:10:13Z","timestamp":1636733413000},"page":"1027-1032","source":"Crossref","is-referenced-by-count":21,"title":["The Quest for an Accurate Functional Tumor Volume with <sup>68<\/sup>Ga-DOTATATE PET\/CT"],"prefix":"10.2967","volume":"63","author":[{"given":"Ryan P.","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ross Schmidtlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina G.","family":"Giancipoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Mauguen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"LaFontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Schoder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Bodei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2021,11,12]]},"reference":[{"key":"2022070608400715000_63.7.1027.1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/CM9.0000000000000109","article-title":"Automated quantification of Ki-67 index associates with pathologic grade of pulmonary neuroendocrine tumors","volume":"132","author":"Wang","year":"2019","journal-title":"Chin Med J."},{"key":"2022070608400715000_63.7.1027.2","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2015.12.003"},{"key":"2022070608400715000_63.7.1027.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607427"},{"key":"2022070608400715000_63.7.1027.4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000367850","article-title":"The status of neuroendocrine tumor imaging: from darkness to light?","volume":"101","author":"Bodei","year":"2015","journal-title":"Neuroendocrinology."},{"key":"2022070608400715000_63.7.1027.5","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-013-2482-z"},{"key":"2022070608400715000_63.7.1027.6","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1007\/s00330-016-4475-3","article-title":"The added value of 68Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine origin","volume":"27","author":"Kazmierczak","year":"2017","journal-title":"Eur Radiol."},{"key":"2022070608400715000_63.7.1027.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1754-9485.2011.02327.x"},{"key":"2022070608400715000_63.7.1027.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009290"},{"key":"2022070608400715000_63.7.1027.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61742-X"},{"key":"2022070608400715000_63.7.1027.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003825"},{"key":"2022070608400715000_63.7.1027.11","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-13-0365"},{"key":"2022070608400715000_63.7.1027.12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41416-019-0558-7","article-title":"Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib: comparison of Choi versus RECIST criteria (CRIPNET_ GETNE1504 study)","volume":"121","author":"Solis-Hernandez","year":"2019","journal-title":"Br J Cancer."},{"key":"2022070608400715000_63.7.1027.13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12885-017-3150-7","article-title":"Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi criteria?","volume":"17","author":"Luo","year":"2017","journal-title":"BMC Cancer."},{"key":"2022070608400715000_63.7.1027.14","doi-asserted-by":"publisher","DOI":"10.7150\/thno.3645"},{"key":"2022070608400715000_63.7.1027.15","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1053\/j.gastro.2017.11.008","article-title":"Prognostic utility of total 68Ga-DOTATATE-avid tumor volume in patients with neuroendocrine tumors","volume":"154","author":"Tirosh","year":"2018","journal-title":"Gastroenterology."},{"key":"2022070608400715000_63.7.1027.16","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/MNM.0000000000000522","article-title":"Combined imaging with 68Ga-DOTA-TATE and 18F-FDG PET\/CT on the basis of volumetric parameters in neuroendocrine tumors","volume":"37","author":"Abdulrezzak","year":"2016","journal-title":"Nucl Med Commun."},{"key":"2022070608400715000_63.7.1027.17","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/s00259-019-04455-9","article-title":"Prognostic value of somatostatin receptor expressing tumor volume calculated from 68Ga-DOTATATE PET\/CT in patients with well-differentiated neuroendocrine tumors","volume":"46","author":"Toriihara","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2022070608400715000_63.7.1027.18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4149\/neo_2018_180328N209","article-title":"Prognostic value of functional tumor burden on 68Ga-DOTATOC PET\/CT in patients with pancreatic neuro-endocrine tumors","volume":"66","author":"Ohnona","year":"2019","journal-title":"Neoplasma."},{"key":"2022070608400715000_63.7.1027.19","doi-asserted-by":"crossref","unstructured":"Ohlendorf F Henkenberens C Brunkhorst T . Volumetric 68Ga-DOTA-TATE PET\/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with metastatic gastroenteropancreatic neuroendocrine tumors. Q J Nucl Med Mol Imaging. April 14, 2020 [Epub ahead of print].","DOI":"10.23736\/S1824-4785.20.03238-0"},{"key":"2022070608400715000_63.7.1027.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2014.04.014"},{"key":"2022070608400715000_63.7.1027.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.nucmedbio.2014.02.006"},{"key":"2022070608400715000_63.7.1027.22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.167684"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.121.262782","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T15:41:32Z","timestamp":1657122092000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.121.262782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,12]]},"references-count":22,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,6,30]]},"published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.2967\/jnumed.121.262782"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.121.262782","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,12]]}}}